prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |review
Janerich et al. “Lung cancer and exposure to tobacco smoke in the household”. N Engl J Med 323:632-636, 1990.
Cardenas et al. “Nonsmoking women married to smokers die of lung cancer more often than women married to nonsmokers.” Environmental tobacco smoke and lung cancer mortality in the American Cancer Society’s Cancer prevention Study II. Cancer causes and Control, 1997:8;57-64.
Mulshine et al. “Application of monoclonal antibodies for use in the early detection and management of lung cancer”. Second International Workshop on Small Cell Lung Cancer Antigens. London 1990.
Gealy et al. “Comparison of Mutations in the p53 and K-ras genes in Lung Carcinomas from smoking and nonsmoking women.”  Cancer Epidemiology, Biomarkers and Prevention 8, 297-302, April 1999.
Tammemagi et al. “Meta-analyses of p53 Tumor Suppressor gene alterations and clinicopathological features in resected lung cancers.” Cancer Epidemiology, Biomarkers and Prevention 8, 625-634, July 1999.
“Lung Cancer: Prevention, Diagnosis and Treatment”. Review from “2nd Nordic Symposium on Lung Cancer”. Editor FR. Hirsch. ISBN 87-984474-1-6.
Gadgeel et al. “Lung cancer in patients < 50 years of age. The Experience of an Academic Multidisciplinary Program.” Chest 115(5): 1232 –1236, 1999.
Anderson et al. “Association of family history of cervical, ovarian and uterine cancer with histological categories of
 lung cancer: The Iowa Women’s Health Study.” Cancer Epidemiology, Biomarkers and Prevention 6, 401-405, June 1997.
Mayne et al. “Familial cancer history and lung cancer risk in United States Nonsmoking men and Women.” Cancer Epidemiology, Biomarkers and Prevention 8, 1065-1069, december 1999
Huber et al. “Chemoprevention of lung cancer”. April 1993, Seminars in Oncology, Vlo.20, No 2. Lung Cancer Part 1, pp 128-141.